The Food and Drug Administration authorized Friday the emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences' lobbying hit a new high in the first quarter.
Read more on NPR
Saturday, 2 May 2020
loobobilly News: Gilead Lobbying Rose As Interest In COVID-19 Treatment Climbed
Labels:
Business
,
loobobillyNPR
The Food and Drug Administration authorized Friday the emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences' lobbying hit a new high in the first quarter.
Read more on NPR
Do You Like This Article
Get Subscribe to Free Email Updates!!
Popular Posts
-
Even as the IITs, IIMs, NITs and universities like JNU, Bombay University are world acclaimed, more and more students are shifting a...
-
Burundi President Pierre Nkurunziza Burundi President Pierre Nkurunziza has promulgated the law on the withdrawal of Burundi from t...
-
The "Asian Games-2017" was presented at the International Convention, "the SportAccord" in Lausanne (Switzerland) ...
-
Prime Minister Narendra Modi on the ‘Rate My Government’ Survey in his Mann ki Baat, broadcast on 26th June, 2016. On the occasion o...
-
Quick Facts Profile Kumar Mangalam is an Indian industrialist and also the Chairman of the Aditya Birla Group, a multi-industrial...
-
The app owned by Twitter will not survive but a new, pared-down version in January will allow users to share short videos to that social net...
-
Peter Thiel, one of Donald J. Trump’s biggest donors in 2016, has re-emerged as a prime financier of the Make America Great Again movement. ...
